Literature DB >> 25029589

Vaccination in HIV-infected adults.

Nancy F Crum-Cianflone1, Mark R Wallace.   

Abstract

Vaccines are critical components for protecting HIV-infected adults from an increasing number of preventable diseases. However, missed opportunities for vaccination among HIV-infected persons persist, likely due to concerns regarding the safety and efficacy of vaccines, as well as the changing nature of vaccine guidelines. In addition, the optimal timing of vaccination among HIV-infected adults in regards to HIV stage and receipt of antiretroviral therapy remain important questions. This article provides a review of the current recommendations regarding vaccines among HIV-infected adults and a comprehensive summary of the evidence-based literature of the benefits and risks of vaccines among this vulnerable population.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25029589      PMCID： PMC4117268          DOI： 10.1089/apc.2014.0121

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


  115 in total

1.  Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Authors:  Helen M Chun; Mollie P Roediger; Katherine Huppler Hullsiek; Chloe L Thio; Brian K Agan; William P Bradley; Sheila A Peel; Linda L Jagodzinski; Amy C Weintrob; Anuradha Ganesan; Glenn Wortmann; Nancy F Crum-Cianflone; Jason D Maguire; Michael L Landrum
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.

Authors:  Zheng Yin; Brian D Rice; Pauline Waight; Elizabeth Miller; Robert George; Alison E Brown; Ruth D Smith; Mary Slack; Valerie C Delpech
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

3.  Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali.

Authors:  Mariam Sidibe; Sergio Yactayo; Abdoulaye Kalle; Amadou A Sall; Samba Sow; Modjirom Ndoutabe; William Perea; Fenella Avokey; Rosamund F Lewis; Olivia Veit
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-05-22       Impact factor: 2.184

4.  Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.

Authors:  George K Siberry; Meredith G Warshaw; Paige L Williams; Stephen A Spector; Michael D Decker; Patrick Jean-Philippe; Ram Yogev; Barbara E Heckman; Adam Manzella; Jhoanna Roa; Sharon Nachman; Jorge Lujan-Zilbermann
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

5.  The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Helen M Chun; Nancy F Crum-Cianflone; Anuradha Ganesan; Amy C Weintrob; R Vincent Barthel; Robert J O'Connell; Brian K Agan
Journal:  Am J Epidemiol       Date:  2010-11-04       Impact factor: 4.897

6.  Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Authors:  Odile Launay; Diane van der Vliet; Arielle R Rosenberg; Marie-Louise Michel; Lionel Piroth; David Rey; Nathalie Colin de Verdière; Laurence Slama; Karine Martin; Olivier Lortholary; Fabrice Carrat
Journal:  JAMA       Date:  2011-04-13       Impact factor: 56.272

7.  Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Kenneth Wilkins; Andrew W Lee; Anthony Grosso; Michael L Landrum; Amy Weintrob; Anuradha Ganesan; Jason Maguire; Stephanie Klopfer; Carolyn Brandt; William P Bradley; Mark R Wallace; Brian K Agan
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

8.  Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Erik Iverson; Gabriel Defang; Patrick J Blair; Lynn E Eberly; Jason Maguire; Anuradha Ganesan; Dennis Faix; Christopher Duplessis; Tahaniyat Lalani; Timothy Whitman; Carolyn Brandt; Grace Macalino; Eugene V Millar; Timothy Burgess
Journal:  Vaccine       Date:  2011-03-01       Impact factor: 3.641

9.  Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Lynn E Eberly; Chris Duplessis; Jason Maguire; Anuradha Ganesan; Dennis Faix; Gabriel Defang; Yun Bai; Erik Iverson; Tahaniyat Lalani; Timothy Whitman; Patrick J Blair; Carolyn Brandt; Grace Macalino; Timothy Burgess
Journal:  Clin Infect Dis       Date:  2010-12-07       Impact factor: 9.079

10.  Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Authors:  Markus Bickel; Nils von Hentig; Imke Wieters; Pavel Khaykin; Gabi Nisius; Annette Haberl; Christoph Stephan; Eva Herrmann; Hans W Doerr; Hans Reinhard Brodt; Regina Allwinn
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079
View more
  18 in total

Review 1.  An immunization update for HIV-infected adults in the United States: review of the literature.

Authors:  Patricia A Cioe; Kathleen Melbourne; Jerome Larkin
Journal:  J Assoc Nurses AIDS Care       Date:  2015 Mar-Apr       Impact factor: 1.354

2.  Predictors of vaccination rates in people living with HIV followed at a specialty care clinic.

Authors:  Tanner M Johnson; Donald G Klepser; Sara H Bares; Kimberly K Scarsi
Journal:  Hum Vaccin Immunother       Date:  2020-09-03       Impact factor: 3.452

3.  Altered immune cell follicular dynamics in HIV infection following influenza vaccination.

Authors:  Eirini Moysi; Suresh Pallikkuth; Lesley R De Armas; Louis E Gonzalez; David Ambrozak; Varghese George; David Huddleston; Rajendra Pahwa; Richard A Koup; Constantinos Petrovas; Savita Pahwa
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

4.  Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.

Authors:  Kellie L Hawkins; Kirsha S Gordon; Myron J Levin; Adriana Weinberg; Catherine Battaglia; Maria C Rodriguez-Barradas; Sheldon T Brown; David Rimland; Amy Justice; Janet Tate; Kristine M Erlandson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

5.  Standard vaccines increase HIV-1 transcription during antiretroviral therapy.

Authors:  Christina Yek; Sara Gianella; Montserrat Plana; Pedro Castro; Konrad Scheffler; Felipe García; Marta Massanella; Davey M Smith
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

6.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

7.  Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.

Authors:  Massimo Andreoni; Laura Sticchi; Silvia Nozza; Loredana Sarmati; Andrea Gori; Marcello Tavio
Journal:  Hum Vaccin Immunother       Date:  2021-09-15       Impact factor: 4.526

8.  Sociodemographic, HIV-Related Characteristics, and Health Care Factors as Predictors of Self-Reported Vaccination Coverage in a Nationwide Sample of People Aging with HIV in Germany.

Authors:  Jochen Drewes; Phil C Langer; Jennifer Ebert; Dieter Kleiber; Burkhard Gusy
Journal:  Int J Environ Res Public Health       Date:  2021-05-04       Impact factor: 3.390

Review 9.  Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.

Authors:  Wim Adriaensen; Thomas P C Dorlo; Guido Vanham; Luc Kestens; Paul M Kaye; Johan van Griensven
Journal:  Front Immunol       Date:  2018-01-12       Impact factor: 7.561

10.  Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.

Authors:  M Teresa Aguado; Jane Barratt; John R Beard; Bonnie B Blomberg; Wilbur H Chen; Julian Hickling; Terri B Hyde; Mark Jit; Rebecca Jones; Gregory A Poland; Martin Friede; Justin R Ortiz
Journal:  Vaccine       Date:  2018-01-12       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.